JNJ CIK: 200406

Johnson & Johnson

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
61.0
FY22:
55.3
FY23:
53.5
FY24:
55.9
FY25:
55.6
(positive)
Change from FY21 to FY25
billions USD
FY21:
121
FY22:
132
FY23:
114
FY24:
124
FY25:
144
Total assets
Change from FY21 to FY25
billions USD
FY21:
182
FY22:
187
FY23:
168
FY24:
180
FY25:
199

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
45.2
FY22:
55.8
FY23:
46.3
FY24:
50.3
FY25:
54.1
(negative)
Change from FY21 to FY25
billions USD
FY21:
62.8
FY22:
54.8
FY23:
52.5
FY24:
58.3
FY25:
63.5
(positive)
Change from FY21 to FY25
billions USD
FY21:
74.0
FY22:
76.8
FY23:
68.8
FY24:
71.5
FY25:
81.5
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
182
FY22:
187
FY23:
168
FY24:
180
FY25:
199

All amounts in billions USD Data source:SEC EDGAR